Forte Biosciences, Inc. — insider transactions

5 transactions on record · CIK 1419041

Aggregates

computed from the filings below
Purchases, 12m
0
count of open-market buys
Sales, 12m
5
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
1
Bought, 3m
$0
Sold, 3m
$0
Median disclosure lag
0.0 d
trade date to filing date
Largest single trade, 24m
—
Director share, 12m
100.0%
of transactions where role is stated
Current run
5 sells
consecutive same-direction transactions
Net 3m flow
$0
purchases minus sales
Total on record
5

Transactions

5 most recent shown
DisclosedTradedLag, dInsiderRoleTransactionSharesPriceValueSource
2026-08-272026-08-270Brun Scott C.DirectorDisposition to issuer2,000——filing
2026-08-272026-08-270Brun Scott C.DirectorDisposition to issuer31,000——filing
2026-08-272026-08-270Brun Scott C.DirectorDisposition to issuer2,000——filing
2026-08-272026-08-270Brun Scott C.DirectorDisposition to issuer1,000——filing
2026-08-272026-08-270Brun Scott C.DirectorDisposition to issuer18,353——filing

Source: U.S. Securities and Exchange Commission, EDGAR

Forte Biosciences, Inc. insider transactions — 5 filings on record — investment.com